DeepEcho

DeepEcho, a Delaware-incorporated health tech company founded in 2020 with headquarters in Rabat, Morocco, is focused on enhancing prenatal care through artificial intelligence. The company was co-founded by CEO Youssef Bouyakhf, who has a background with JP Morgan & Macquarie in London and co-founded Morocco's first AI Lab; Chief Medical Officer Dr. Saad Slimani, a radiology resident at Casablanca University Hospital; and CTO Abdelhak Mahmoudi, a Professor of Computer Science at Mohammed V University. The founding team's collective expertise in finance, AI, computer vision, and clinical radiology underpins the company's mission.

The core of DeepEcho's business is an AI-driven software platform designed to assist healthcare professionals in analyzing fetal ultrasounds. The technology utilizes deep learning algorithms to automate the identification of fetal structures, calculate biometric measurements, and assess amniotic fluid volume. This computer-assisted diagnosis tool is hardware-agnostic and can be integrated into existing medical workflows, serving both experienced radiologists and minimally trained clinicians in under-resourced areas. By automating and standardizing analyses, the software aims to improve diagnostic accuracy to over 95% and speed up screenings by three to five times. A significant milestone was achieved in June 2025, when the platform received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

DeepEcho operates on a business-to-business model, partnering with hospitals and health centers to deploy its software. The company's goal is to democratize access to high-quality prenatal diagnostics globally, addressing critical issues like Fetal Growth Restriction (FGR), preeclampsia, and other congenital complications that contribute to maternal and infant mortality. The company is also developing next-generation solutions to identify novel biomarkers for the early prediction of complex conditions. DeepEcho has secured partnerships with multiple health centers in Morocco and possesses one of the world's largest annotated fetal ultrasound datasets to train its algorithms. The company has received funding from investors including UM6P Ventures, Plug and Play, the Bill & Melinda Gates Foundation, and Google for Startups.

Keywords: prenatal care, fetal ultrasound, artificial intelligence, medical imaging, healthtech, deep learning, computer-assisted diagnosis, maternal health, Fetal Growth Restriction (FGR), prenatal diagnostics, teleguidance, remote diagnosis, FDA clearance, medical software, clinical decision support, fetal biometry, ultrasound automation, Morocco, predictive diagnostics, neonatal mortality